EAM
RGNX icon

Exome Asset Management’s Regenxbio RGNX Stock Holding History

Exome Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-226,060
Closed -$1.86M – 92
2025
Q2 		$1.86M Sell
226,060
-179,221
-44% -$1.5M 1.38% 32
2025
Q1 		$2.9M Buy
+405,281
New +$3.01M 2.58% 15
2024
Q2 		– Sell
-84,470
Closed -$1.78M – 68
2024
Q1 		$1.78M Buy
+84,470
New +$1.5M 1.52% 26

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exome Asset Management's RGNX Position: Q3 2025 in Review

Exome Asset Management sold out of Regenxbio (RGNX) in Q3 2025, closing a stake of 226,060 shares — an estimated $1.86M sold.

Exome Asset Management first reported a position in RGNX in Q1 2024 and held it in 3 quarters. The position peaked at $2.9M in Q1 2025. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2025.

  • Exome Asset Management reported no remaining Regenxbio position as of Q3 2025 after selling out during the quarter.
  • Exome Asset Management sold 226,060 Regenxbio shares in Q3 2025, an estimated $1.86M.
  • Exome Asset Management first reported a position in Regenxbio in Q1 2024 and held it in 3 quarters.
  • Exome Asset Management's Regenxbio position peaked at $2.9M in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2025.

Based on Exome Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.